ADVFN ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Premium IconPremium Help Menu
Índice Bovespa
135.510,99
0,19%
S&P 500
6.263,70
0,32%
US Dollar vs BRL
5,5683
0,00%
Bitcoin
118.206,69
-0,44%
Brent Oil
67,895
-0,36%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. United Therapeutics Corporation (UTHR)

  7. United Therapeutics Corporation (UTHR) Notícias

UTHR

United Therapeutics (UTHR)

United Therapeutics Corporation
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:UTHR
DataHoraFonteTítuloCódigoCompanhia
16/07/202508:00Business WireUnited Therapeutics Corporation to Report Second Quarter 2025 Financial Results Before Market Open on Wednesday, July 30, 2025NASDAQ:UTHRUnited Therapeutics Corporation
14/07/202517:30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
10/07/202517:22Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:UTHRUnited Therapeutics Corporation
27/06/202508:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:UTHRUnited Therapeutics Corporation
24/06/202508:00Business WireUnited Therapeutics and Intermountain Health Announce the First Patient Treated With External Liver Support Using a Bioengineered LiverNASDAQ:UTHRUnited Therapeutics Corporation
23/06/202508:00Business WireUnited Therapeutics Corporation Concludes Enrollment of the ADVANCE OUTCOMES Study of Ralinepag for the Treatment of Pulmonary Arterial HypertensionNASDAQ:UTHRUnited Therapeutics Corporation
02/06/202511:12IH Market NewsLiquidia Shares Climb After First Commercial Shipment of YUTREPIANASDAQ:UTHRUnited Therapeutics Corporation
30/05/202517:30Edgar (US Regulatory)Form SD - Specialized disclosure reportNASDAQ:UTHRUnited Therapeutics Corporation
30/04/202507:32Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:UTHRUnited Therapeutics Corporation
30/04/202507:30Business WireUnited Therapeutics Corporation Reports First Quarter 2025 Financial ResultsNASDAQ:UTHRUnited Therapeutics Corporation
29/04/202507:36Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:UTHRUnited Therapeutics Corporation
29/04/202507:33Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:UTHRUnited Therapeutics Corporation
29/04/202507:31Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:UTHRUnited Therapeutics Corporation
21/04/202508:00Business WireUnited Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the American Thoracic Society 2025 International ConferenceNASDAQ:UTHRUnited Therapeutics Corporation
16/04/202508:00Business WireUnited Therapeutics Corporation to Report First Quarter 2025 Financial Results Before Market Open on Wednesday, April 30, 2025NASDAQ:UTHRUnited Therapeutics Corporation
04/04/202508:00Business WireUnited Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the International Society for Heart and Lung Transplantation 45th Annual Meeting and Scientific SessionsNASDAQ:UTHRUnited Therapeutics Corporation
02/04/202513:00Business WireUnited Therapeutics Named to ‘100 Best Companies to Work For’ in 2025 by Fortune Media and Great Place to WorkNASDAQ:UTHRUnited Therapeutics Corporation
26/02/202508:33Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:UTHRUnited Therapeutics Corporation
26/02/202508:30Business WireUnited Therapeutics Corporation Reports Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:UTHRUnited Therapeutics Corporation
24/02/202509:00Business WireUnited Therapeutics Corporation to Present at the TD Cowen 45th Annual Health Care ConferenceNASDAQ:UTHRUnited Therapeutics Corporation
19/02/202509:00Business WireUnited Therapeutics Corporation to Report Fourth Quarter and Full Year 2024 Financial Results Before the Market Opens on Wednesday, February 26, 2025NASDAQ:UTHRUnited Therapeutics Corporation
04/02/202509:00Business WireUnited Therapeutics Corporation Announces Full Enrollment of the TETON 1 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary FibrosisNASDAQ:UTHRUnited Therapeutics Corporation
03/02/202509:00Business WireUnited Therapeutics Corporation Announces FDA Clearance of its Investigational New Drug Application for the UKidney Xenotransplantation Clinical TrialNASDAQ:UTHRUnited Therapeutics Corporation
21/01/202509:00Business WireUnited Therapeutics Corporation to Feature Clinical Data Across its Commercial and Development Portfolio at the Pulmonary Vascular Research Institute 2025 Annual CongressNASDAQ:UTHRUnited Therapeutics Corporation
06/01/202509:00Business WireUnited Therapeutics Corporation to Present at the 43rd Annual J.P. Morgan Healthcare ConferenceNASDAQ:UTHRUnited Therapeutics Corporation
17/12/202409:00Business WireUnited Therapeutics Announces Successful World’s First UKidney TransplantNASDAQ:UTHRUnited Therapeutics Corporation
08/11/202418:30Edgar (US Regulatory)Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]NASDAQ:UTHRUnited Therapeutics Corporation
05/11/202418:30Business WireUnited Therapeutics Corporation to Present at the UBS Global Healthcare ConferenceNASDAQ:UTHRUnited Therapeutics Corporation
30/10/202407:30Business WireUnited Therapeutics Corporation Reports Third Quarter 2024 Financial ResultsNASDAQ:UTHRUnited Therapeutics Corporation
23/10/202408:00Business WireUnited Therapeutics Corporation Announces the 500th Lung Transplant Utilizing its Centralized Ex Vivo Lung Perfusion ServiceNASDAQ:UTHRUnited Therapeutics Corporation
 Apresentando as notícias mais relevantes sobre:NASDAQ:UTHR

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
GOLL4
GOL PN
BOV
AZEV4
AZEVEDO PN
Delayed Upgrade Clock
ADVFN
Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN Ltd - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios